IAN T. BOTHWELL - 10 May 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
10 May 2021
Net transactions value
-$44,300
Form type
4
Filing time
12 May 2021, 21:45:31 UTC
Previous filing
07 May 2021
Next filing
17 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $13,700 -50,000 -0.03% $0.2740 149,845,000 10 May 2021 Direct
transaction OCEL Common Stock Sale $17,500 -50,000 -0.03% $0.3500 149,795,000 11 May 2021 Direct
transaction OCEL Common Stock Sale $13,100 -50,000 -0.03% $0.2620 149,745,000 12 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.